Get the free version of Marbridge Daily delivered to your inbox

Click here to subscribe

Tencent Launches AI Medical Imaging Product, 8/04/17

Chinese internet and mobile services firm Tencent (0700.HK) recently announced a new AI medical imaging product for medical applications, called AI Medical Innovation System (AIMIS) ("Miying" in Chinese).

AIMIS includes six artificial intelligence systems covering different diseases, including esophageal cancer, lung cancer, diabetic retinopathy, cervical cancer and breast cancer. Of these systems, Tencent's early-stage esophageal cancer screening system has already entered the pre-clinical testing stage and has a reported accuracy rate of 90%. The system has been undergoing trials in Shenzhen's Nanshan District People's Hospital for over one month and provides screening services for dozens of patients every day.

Tencent also announced that it has set up an artificial intelligence medical screening joint laboratory and initiated clinical pre-testing for its esophageal cancer early screening program in partnership with Guangdong Second People's Hospital and Nanshan District People's Hospital.

Keywords: online healthcare AIMIS Internet Tencent 0700.HK artificial intelligence


Please note, all fields are required.
None of your personal information will be shared with third parties.



The information contained in this newsletter is based upon sources that Marbridge Consulting believes to be reliable, and we have made every effort to translate the original articles or article excerpts as faithfully as possible. However, Marbridge Consulting makes no warranty of and assumes no legal responsibility for the accuracy of either the original source material or the English language translations.

Marbridge Daily Premium

Interested in gaining full access to all newsletter articles and the Marbridge Daily archive? To learn more about premium subscription options, including pricing, please:

Click here

Marbridge Consulting RSS Feed

Marbridge Reports